Although the yield may be less than expected, pancreas screening can detect high-risk lesions in time for lifesaving treatment in people deemed to have a genetic susceptibility for developing pancreatic cancer, according to early results of the multicenter, prospective Pancreas Scan Study.
“Screening detected high-risk lesions in 0.8% of patients, which was lower than the 3% typically reported in the literature for screening high-risk individuals,” said investigator Andy